Back to Search
Start Over
Percutaneous Auricular Nerve Stimulation (Neuromodulation) for Analgesia and Opioid-Sparing Following Knee and Hip Arthroplasty: A Proof-of-Concept Case Series.
- Source :
-
A&A practice [A A Pract] 2022 Oct 14; Vol. 16 (10), pp. e01621. Date of Electronic Publication: 2022 Oct 14 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- We present a case series to demonstrate proof-of-concept for the off-label use of an auricular neuromodulation device-originally developed to treat symptoms associated with opioid withdrawal-to instead provide analgesia and opioid-sparing following knee and hip arthroplasties. Within the recovery room, an auricular neuromodulation device (near-field stimulator system 2 [NSS-2] Bridge, Masimo) was applied to 5 patients. Average daily pain at rest and while moving was a median of 0 to 2 as measured on the 0 to 10 numeric rating scale, while median daily oxycodone use was 0 to 2.5 mg until device removal at home on postoperative day 5. One patient avoided opioid use entirely.<br />Competing Interests: Conflicts of Interest: See Disclosures at the end of the article.<br /> (Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the International Anesthesia Research Society.)
Details
- Language :
- English
- ISSN :
- 2575-3126
- Volume :
- 16
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- A&A practice
- Publication Type :
- Academic Journal
- Accession number :
- 36240466
- Full Text :
- https://doi.org/10.1213/XAA.0000000000001621